<--- Back to Details
First PageDocument Content
Hemoglobins / Hemoglobin E / Sickle-cell disease / Gene therapy / Hemoglobin / Beta thalassemia / Thalassemia / Mucositis
Date: 2016-05-16 12:24:16
Hemoglobins
Hemoglobin E
Sickle-cell disease
Gene therapy
Hemoglobin
Beta thalassemia
Thalassemia
Mucositis

Marina Cavazzana [Mode de compatibilité]

Add to Reading List

Source URL: www.hemapherese.fr

Download Document from Source Website

File Size: 1,41 MB

Share Document on Facebook

Similar Documents

Marina Cavazzana [Mode de compatibilité]

Marina Cavazzana [Mode de compatibilité]

DocID: 1p4cO - View Document

I would like to donate Name ............................................................................................... Diagnostic Lab Thalassemia & Sickle Cell Society Vuppala Krishna Rao & Chandrakala Diagnostic

I would like to donate Name ............................................................................................... Diagnostic Lab Thalassemia & Sickle Cell Society Vuppala Krishna Rao & Chandrakala Diagnostic

DocID: 1oVFa - View Document

Sickle Cell Awareness  Sickle Cell Disease (SCD) is an assembly of inherited red blood cell disorders. People with SCD have abnormal hemoglobin, termed as hemoglobin S or sickle hemoglobin, in their red blood cells. Inhe

Sickle Cell Awareness Sickle Cell Disease (SCD) is an assembly of inherited red blood cell disorders. People with SCD have abnormal hemoglobin, termed as hemoglobin S or sickle hemoglobin, in their red blood cells. Inhe

DocID: 1onjc - View Document

Beta Thalassemia Genetic Testing Interpretation Order Form Patient´s name (first name, last name)

DocID: 1crRW - View Document

CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific

CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific

DocID: 19vEv - View Document